Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma by unknown
Qu et al. Journal of Experimental & Clinical Cancer Research 2013, 32:75
http://www.jeccr.com/content/32/1/75RESEARCH Open AccessNumber of glioma polyploid giant cancer cells
(PGCCs) associated with vasculogenic mimicry
formation and tumor grade in human glioma
Yang Qu1†, Li Zhang3†, Zhe Rong4, Tao He5 and Sai Zhang1,2*Abstract
Background: Polyploid giant cancer cells (PGCCs) contribute to solid tumor heterogeneity. This study investigated
the relationships among PGCCs numbers, vasculogenic mimicry (VM) formation, and tumor grades in glioma.
Methods: A total of 76 paraffin-embedded glioma tissue samples, including 28 cases of low grade and 48 cases of
high grade gliomas, were performed with H&E and immunohistochemical staining for Ki-67 and hemoglobin. The size
of PGCCs nuclei was measured by a micrometer using H&E section and defined as at least three times larger than the
nuclei of regular diploid cancer cells. The number of PGCCs and different blood supply patterns were compared in
different grade gliomas. Microcirculation patterns in tumors were assessed using CD31 immunohistochemical and PAS
histochemical double staining. Human glioma cancer cell line C6 was injected into the chicken embryonating eggs to
form xenografts, which was used to observe the PGCCs and microcirculation patterns.
Results: In human glioma, the number of PGCCs increased with the grade of tumors (χ 2 = 4.781, P = 0.015). There were
three kinds of microcirculation pattern in human glioma including VM, mosaic vessel (MV) and endothelium dependent
vessel. PGCCs were able to generate erythrocytes via budding to form VM. The walls of VM were positive (or negative)
for PAS staining and negative for CD31 staining. There were more VM and MVs in high grade gliomas than those in low
grade gliomas. The differences have statistical significances for VM (t = 3.745, P = 0.000) and MVs (t = 4.789, P = 0.000).
PGCCs, VM and MVs can also be observed in C6 chicken embryonating eggs xenografts.
Conclusions: The data demonstrated presence of PGCCs, VM and MVs in glioma and PGCCs generating erythrocytes
contribute the formation of VM and MVs.
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Polyploid giant cancer cells (PGCCs) refer to the special
sub-population of cancer cells [1,2] and usually have
increased cell size with single giant nuclei or multinuclei
with significant variation in shape, chromatin pattern, and
number of nuclei. The PGCCs are the most commonly
described histopathology features of human tumors,
particularly in high grade and advanced stage tumor and* Correspondence: tjquyang59@163.com
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reproduction in any medium, provided the orusually correlate with poor prognosis [3-5]. PGCCs have
often been considered an intermediate product of genomic
instability [6-10], although the mechanisms of the PGCCs
formation and their function in the development of
human cancer are largely undefined. PGCCs remarkably
differ from regular diploid cancer cells in morphology,
size, chromosomal abnormalities, tumorigenic ability, radio-
resistance and chemoresistance. Indeed, these cells may
contribute to tumor maintenance and recurrence. Zhang
et al. reported that PGCCs had remarkable biologic features
of cancer stem cells [11,12]. PGCCs could form through
endoreduplication or cell fusion. PGCCs divided asymmet-
rically and cycled slowly, contributed to the heterogeneous
tumor growth and drug resistance, which can be considered
as the seed cells fueling the growth and recurrence of. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with the malignant grade of tumor. There are more
PGCCs in malignant tumor than those in benign, in high
grade tumor than those in low grade tumor [11].
Angiogenesis is the physiological process involving the
growth of new blood vessels from pre-existing blood
vessels. Angiogenesis is also a vital process in embryonic
development, wound healing, and carcinogenesis. Cancer
development usually undergoes an initial period of avascu-
lar growth followed by vasculogenic mimicry (VM) and
mosaic vessels (MVs) that connect with endothelium
dependent vessels to obtain sufficient blood and oxygen
supply to support tumor cell growth, invasion, and metas-
tasis [13,14]. More aggressive tumors require more blood
supply to support their rapid cell growth than that in the
low grade tumors. VM has increasingly been recognized
as a pattern of angiogenesis. Accumulating evidences have
demonstrated that high grade malignant tumors including
inflammatory breast cancer [15], prostate cancer [16],
and invasive ovarian cancer [17], sarcoma [18,19], and he-
patocellular carcinoma [14] utilize VM to support tumor
cell growth, invasion and metastasis. Erythrocytes carry
oxygen to tissues and cells, and bone marrow is gene-
rally considered the main source of erythrocytes. How-
ever, Zhang et al. showed that cobalt chloride (CoCl2)
treatment of HEY, SKOv3, BT-549 and MDA-MB-231
cells was able to form PGCCs, express the stem cell
markers, and induce generation of erythrocytes expressing
different forms of hemoglobin both in vitro and in vivo
[20]. Since tumor cells can generate erythrocytes, it is no
doubt that tumor cells and their generating erythrocytes
can form VM structure during tumor development and
progression.
High grade malignant glioma is one of the leading causes
of cancer death in many countries and the prognosis is
very poor [21,22]. Therefore, in this study, we determined
whether VM and PGCCs are present in human gliomas
and then associate with tumor grade, and whether
PGCCs-generated erythrocytes contributed the formation
of VM and MVs.
Methods
Tissue samples
A total of 76 paraffin-embedded glioma tissues were
obtained from the Tumor Tissue Bank of Tianjin Union
Medicine Center and Logistic University of Chinese
People's Armed Police Force. The patients underwent
surgery between 1995 and 2009 and the diagnosis was
verified by pathologists. These patients included 42
males and 34 females and were histologically divided
into two groups, 28 cases of low grade gliomas (grade I
and II with the mean age of 32.47 ± 1.97) and 48 cases of
high grade gliomas (grade III and IV with the mean age of
50.41 ± 1.89) according to the World Health Organization(WHO) classification based on the morphology and
Ki-67 immunohistochemical staining. This study was
approved by the institutional research committee
and the confidentiality of patients’ information has been
maintained.
Immunohistochemical (IHC) and histochemical
double-staining
To confirm the identity of the cells lining the walls and
whether VM was present in the tissues, formalin-fixed
and paraffin-embedded tissues were cut at 4 μm, dried
for 2 h at 60°C and then deparaffinized in xylene and
rehydrated in a series of alcohol. Subsequently, heat-
induced epitope retrieval was achieved in 0.01 M citric
acid buffer (pH = 6.0) in a microwave oven and endogenous
peroxidase activity was blocked with 3% hydrogen peroxide
for 10 min. The primary monoclonal mouse anti-CD31
(MAB-0031, Maixin.Bio, Fujian, China), Ki-67 (MAB-0672,
Maixin.Bio, Fujian, China) and goat polyclonal anti-
hemoglobin-β/γ/ε/δ chain (Santa Cruz Biotechnology Inc.
sc-22718)antibodies were used at a dilution of 1:100.
The MaxVision™/HRP (Maixin.Bio) was used. Visualization
was performed using the diaminobenzidine method
(Maixin.Bio).
Review of scoring Ki-67 stained tissue sections
and glioma grading
Tumor cells with brown nuclei were considered positive.
We reviewed five fields per section at 400× magnification
and positive cells were counted in 100 tumor cells for each
field. The mean percentage of positive cells was used to
assess the grading of gliomas.
Assessment and quantification of different blood supply
patterns
Five microscopic fields in each tissue section were reviewed
under microscopy with × 400 magnification and the average
was considered as the number of different blood supply
patterns. Endothelial dependent vessels (EVs) counting
standard: According to the standard introduced by
Weidner et al. [23,24], capillary vessels and microvessels
in the tumor stained with CD31 were counted. A single
positively stained endothelial cell can be counted as one
EV. VM counting standard: The wall of VM is lined with
tumor cells, and red cells can be found in the VM, without
inflammation cells or red cell leakage around the VM [25].
MVs counting standard: The vessel wall was lined with
both tumor and endothelial cells [14,25].
PGCCs counting and definition
Five microscopic fields in each tissue section were reviewed
and scored under microscopy with × 400 magnification
and the average was summarized. The size of PGCCs
nuclei was measured by a micrometer using H&E section.
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PGCC is at least three times larger than that of diploid
cancer cell according to Zhang et al. description [11].Tumor xenografts in chicken embryonating eggs
Fresh fertilized eggs (less than 5 days after fertilization)
(Tianjin Shengchi Inc.) were kept under 75% humidity
and 37°C. At day 3 after incubation, the egg shell was
cleaned with 75% ethanol. A square window (1 × 1 mm2)
was opened in the end of air cell. The shell was removed
and 0.1 ml PBS with 5 × 106 glioma C6 cells was injected
into the chorioallantoic membrane (CAM) of each egg.
The opening was then closed with a cellophane tape and
the eggs were incubated until the 20th day. All these oper-
ations were performed in the sterile environment. These
fertilized eggs were rotated with 45 degrees every day and
the air cell end was always kept upright. At day 20 after
incubation, the fertilized eggs were put into the −20°C
freezer to kill the chicken embryos and then the tumor
mass were dissociated. The tumor tissues were fixed with
formalin and embedded with paraffin for H&E staining to
observe the structure of different blood supply patterns
and erythrocytes generated by PGCCs.Figure 1 Identification of PGCCs in glioma tissues. A. PGCCs present in
(×200). b) PGCCs in grade II gliomas (Black arrows point) (×200). c) PGCCs
gliomas (Black arrows point) (×200). B. Ki-67 IHC staining in gliomas and bl
(×200). b) Ki-67 expression in grade II gliomas (×200). c) Ki-67 expression in
(×200). C. Association of PGCCs number with the grades of human gliomasStatistical analysis
The statistical analysis was performed using SPSS statistical
analysis software (SPSS, Chicago, IL). An unpaired t-test
was performed to analyze the differences in the number
of VM, MVs and EVs. The χ 2 test was used for the
PGCCs number comparison among different grades of
gliomas. A P-value less than 0.05 was considered statisti-
cally significance.
Results
Number of PGCCs associated with histologic grade
of gliomas
To grade all these 76 cases of glioma, new sections were
cut from 76 paraffin-embedded glioma samples and stained
with H&E and immunohistochemistry for further analysis.
These tumors were graded by two pathologists according
to the morphologic characteristics and Ki-67 IHC staining.
Results of micrometer measure and morphologic observa-
tion showed presence of PGCCs in glioma tissues with
giant or multi nuclei (Figure 1A). The size of PGCC
nucleus was three times and up to 10–20 times larger than
that of the regular diploid cancer cell. The shape of
PGCCs nuclei was irregular. Ki-67 IHC staining data
showed that Ki-67 expressed in all the glioma tissues andhuman gliomas. a) PGCCs in grade I gliomas (Black arrow points)
in grade III gliomas (Black arrows point) (×200). d) PGCCs in grade IV
ack arrows indicate the PGCCs. a) Ki-67 expression in grade I gliomas
grade III gliomas (×200). d) Ki-67 expression in grades IV gliomas
.
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of PGCCs were positive for Ki-67 staining (Figure 1B).
Based on these morphologic characteristics and Ki-67
staining, 76 cases of glioma were graded into 28 cases
of low grade glioma (4 cases of grade I and 24 cases of
grade II) and 48 cases of high grade (28 cases of grade
III and 20 cases of grade IV). PGCCs can be observed
in all these glioma tissues (Figure 1A), but there were
more PGCCs in high grade tumors than those in low
grade tumors and the difference was statistically signifi-
cant (χ 2 = 4.781, P = 0.015) (Figure 1C).
Erythrocyte generation by PGCCs
Zhang et al. reported that PGCCs of breast cancer cell line
BT-549 was able to generate erythrocytes in vitro and
in vivo [20]. To determine whether glioma PGCCs can
directly generate erythrocytes, H&E and anti-hemoglobin-
β/γ/ε/δ chain IHC staining were performed on glioma
tissue sections and the results showed that there were
many red bodies budding from PGCCs. These red bodies
located in the cytoplasm or adhered to the surface of
PGCCs (Figure 2A -a). Figure 2A-b showed that some red
bodies located in the cytoplasm of PGCC. An interesting
phenomenon indicated that some PGCCs generating
erythrocytes form the wall of VM and MVs. Figure 2A-c
showed that PGCCs and their generating erythrocytes can
form VM structure and PGCCs lined in the basementFigure 2 Human high grade glioma cells generated
erythrocytes. a) H&E staining showed that there were many red
bodies adhered to the surface of PGCCs (Black arrows point) (×200).
b) Red bodies located in the cytoplasm of PGCC (Black arrows point)
(×200). c) PGCCs and their budding erythrocytes form vessel-like
structure with basement membrane (Black arrows point) (×200). d)
IHC staining of hemoglobin-β/γ/ε/δ confirmed that the red bodies
generated by PGCCs were erythrocytes (Red arrows point) (×200).membrane of VM. Hemoglobin-β/γ/ε/Δ IHC staining
confirmed that these red bodies generated by PGCCs
were erythrocytes (Figure 2A -d).
Different patterns of blood supply in glioma tissues
Different microcirculation patterns including VM, MVs
and EVs appeared in glioma tissues with different grades.
Figure 3A showed the different microcirculation patterns in
glioma sections with H&E staining. Typical EVs were made
of endothelial cells and basement membrane (Figure3A -a).
Some PGCCs generating erythrocytes formed the wall
of MVs (Figure 3A -b) and VM (Figure 3A -c). To further
confirm the structure of different microcirculation patterns
in gliomas, the sections were double-stained with endothe-
lial cell-specific marker CD31 and PAS (basement mem-
brane is positive for PAS staining). VM was identified by
the presence of red blood cells in vessels lined by tumor
cells, not by endothelial cells. As shown in Figure 3B,
the wall of EVs was both positive for CD31 and PAS
staining (Figure 3B-a). A single cell was positive for
CD31 staining and the other cells were negative for MVs
wall (Figure 3B-b). The wall of VM was negative for
CD31 and PAS staining (Figure 3B-c). The average of
VM counting in low grade and high grade gliomas was
0.7 ± 0.675 and 4.1 ± 0.994, respectively. There were more
VM in high grade gliomas than that in low grade gliomas
and the differences was statistically significant (Table 1).
The wall of MVs was lined by both tumor and endothelial
cells and there were more MVs in high grade gliomas than
that in low grade gliomas (t = 4.789, P = 0.000; Table 1).
Presence of PGCCs, VM and MVs in chicken embryonating
eggs with C6 xenografts
Different circulation patterns were further confirmed in
chicken embronating eggs with C6 xenografts because of
the nucleated red blood cells in chicken. We generated
the xenografts in the chicken embryonating eggs with
glioma C6 cell (Figure 3C -a). These xenografts were
fixed with formalin. H&E staining data showed that VM
appeared in the xenografts with nucleated red blood
cells in it (Figure 3C –b and -c). Furthermore, MVs
formed by endothelial and tumor cells occurred in C6
xenografts with nucleated red blood cells in the channels
of MVs (Figure 3C -d). PGCCs can also be observed in
glioma cell C6 xenografts (Figure 3C –e and -f ).
Discussion
Glioma is a type of tumor that occurs in the brain or
spine. Glioma makes up to 30% of all brain and central
nervous system tumors and 80% of all malignant brain
tumors [26,27]. Glioma can be categorized according to
their grade, which is determined by pathologic evaluation
of the tumor. Low grade glioma is well-differentiated,
more benign with better prognosis [28]. Low grade gliomas
Table 1 The average number of VM, MVs and EVs in high
and low grade human glioma
Low grade High grade t p value
(I & II, n = 28) (III & IV, n = 48)
VM 0.7 ± 0.675 4.1 ± 0.994 3.745 0.000
MVs 0.4 ± 0.516 2.6 ± 0.966 4.789 0.000
EVs 10.4 ± 3.03 14.7 ± 3.47 5.984 0.043
VM, vasculogenic mimicry; MVs, mosaic vessels; EVs,
endothelium-dependent vessels.
Figure 3 Different blood supply patterns in human glioma
tissues and C6 glioma cell xenografts. A. Different blood supply
patterns including EVs, MVs and VM in human gliomas. a) EVs in
high grade gliomas (Black arrows point) (H&E × 200). b) Tumor cells
(Large black arrow points) and endothelial cells (Small black arrow
points) formed the structure of MV with red blood cells in it (H&E,
×400). c) VM in human high grade gliomas. Tumor cells formed the
wall of VM (Black arrow points) with red blood cells in it (H&E, ×200).
B. Double staining with CD31 IHC staining and PAS histochemical
staining confirmed the wall structures of EVs, MVs and VM in human
high grade gliomas. a) EVs were positive both for CD31 and PAS
staining (Black arrows point) (×200). b) Tumor cells (CD31 negative
staining, large black arrow points) and endothelial cells (CD31
positive staining, small black arrow points) formed the MV (×200). c)
The wall of VM (black arrow points) was negative for CD31 staining
and positive for PAS staining (×200). C. MVs, VM and PGCCs in
human glioma cancer cell line C6 xenograft of chicken
embryonating eggs. a) The gross imagine of the embryonating egg
xenograft model (Black arrow point the tumor mass). b and c) VM in
C6 xenografts with nucleated red blood cells in it (Black arrows
point) (HE,×200). d) Tumor cells (Black arrow points) and endothelial
cells (Blue arrow points) formed the structure of MVs with nucleated
red blood cells in it (H&E, ×200). e and f) Presence of PGCCs in the
embryonating eggs xenografts (Black arrows point) (H&E, ×200).
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or not based on the locations and symptoms. However,
high grade glioma is more undifferentiated and malignant
with poor prognosis [29]. Morphologic characteristics and
proliferation rate which indicate by Ki-67 IHC staining are
the basis of the glioma grading [30,31]. The Ki-67 proteinis a cellular marker for proliferation [32,33] and often used
to assess the glioma grade [31,34].
Extensive areas of necrosis often appear in high grade
glioma, which indicate the hypoxic microenvironment in
tumor. The normal response to hypoxia is to stimulate
the growth of new blood vessels and other blood supply
patterns. Tumor hypoxia is well recognized as a major
driving factor related with many tumor biological behaviors
and associated with the formation and maintenance of
cancer stem cells [35,36]. Previous studies showed that
hypoxia can promote the self-renewal capability of the
stem and non-stem cell population as well as promoting
stem-like phenotype expression in the non-stem popu-
lation and tumorigenesis [37]. Hypoxia can prevent the
differentiation of neural stem cells in vitro [38]. PGCCs is
an important heterogeneity of solid human cancers [1,2]
and Zhang et al. reported that PGCCs had the properties
of cancer stem cell and could be induced by hypoxic
condition [11]. PGCCs are the most commonly described
histopathology features of human tumors, particularly in
high grade and advanced stage of the disease and thus,
usually correlate with poor prognosis [3-5]. High grade
glioma is typically heterogeneous [39]. Results of our
current study confirmed that there were more PGCCs in
high grade gliomas than those in the low grade gliomas,
which may indicate that the number of PGCCs associated
with hypoxia condition in high grade gliomas. Furthermore,
most of the PGCCs located around the necrotic areas
and the boundary between normal and tumor tissue. The
hypoxic microenvironment around the necrosis induced
the formation of PGCCs. In the boundary, tumor cells
need sufficient oxygen and nutrient to form the “infiltra-
tion striker” invading into the normal tissue. The “relative”
hypoxia can also induce the formation of PGCCs.
Tumor cells can express angiogenesis factors and recruit
normal endothelial cells to form neoangiogenesis to sup-
port tumor proliferation and expansion. Neoangiogenesis is
a well-established mechanism that sustains the aggressive
growth of high-grade tumors [40-42]. VM and MVs are
independent of traditional angiogenesis. The wall of VM is
lined by tumor cells and/or basement membrane, and
no endothelial cells are found on its inner wall. MV is
another type of pattern, where the wall of MVs is lined
both endothelial cells and tumor cells randomly. Red
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number of VM and MVs were also associated with
tumor grade, invasion and metastasis. In this study, we
provided evidences that the number of VM and MVs
were associated with the grade in gliomas. High grade
glioma has extensive areas of necrosis, where the hypoxic
microenvironment can stimulate the formation of new
blood supply patterns besides PGCCs formation.
In the beginning of this study, we unexpectedly found
many red bodies located in the cytoplasm or around the
PGCCs, which form the structures of VM and MVs. IHC
staining confirmed that these red bodies were positive for
hemoglobin-β/γ/ε/δ. These red bodies were neither red
blood cells derived from the hemorrhage, which there is
diffuse red blood cells distribution during the process of
hemorrhage, nor russell bodies which were homogenous
immunoglobulin. Zhang et al. reported that many kinds of
cancer cell line were able to directly generate hemoglobin
and erythrocytes both in vitro and in vivo using hypoxia
mimic CoCl2 [20]. VM was first reported by Maniotist in
1999 [43]. However, the detailed process of VM formation
and origin of erythrocytes is still unclear. Since tumor cells
can generate erythrocytes, we can infer that tumor cells
and their generating erythrocytes can form VM or MVs
structure in high grade tumor. Our data provided a novel
concept to understand VM formation though the current
study is just a proof-of-principle. However, most of experi-
mental data in our study are descriptive and the detailed
molecular mechanisms need to be provided in the future.Conclusions
The number of PGCCs, VM and MVs increased with the
malignant grade in gliomas. PGCCs generated erythrocytes
to form VM and MVs.
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